Yang-Wu Ren Selected Research

Dual Specificity Phosphatase 6

1/2018	Dual-specificity phosphatase 6 genetic variants associated with risk of lung squamous cell carcinoma in Han Chinese.
2/2017	Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese.
1/2016	Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yang-Wu Ren Research Topics

Disease

3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 01/2016
3	Neoplasms (Cancer) 02/2017 - 03/2012
3	Lung Neoplasms (Lung Cancer) 02/2017 - 01/2014
2	Adenocarcinoma of Lung 01/2014 - 01/2013
1	Neoplasm Metastasis (Metastasis) 04/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2018
1	Weight Loss (Weight Reduction) 02/2017
1	Cleft Lip (Harelip) 01/2014

Drug/Important Bio-Agent (IBA)

3	Dual Specificity Phosphatase 6IBA 01/2018 - 01/2016
2	ORALIT (ORS)IBA 01/2014 - 03/2012
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2014
1	AcetyltransferasesIBA 01/2014
1	Oral ContraceptivesIBA 01/2014
1	prolyl-proline (Pro-Pro)IBA 01/2013
1	SmokeIBA 01/2013
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2013
1	arginylarginine (Arg-Arg)IBA 01/2013
1	Environmental CarcinogensIBA 03/2012

Therapy/Procedure

2	Chemoradiotherapy 02/2017 - 01/2016
1	Therapeutics 04/2020
1	Radiotherapy 02/2017